Table 2

Treatment description by period
Period 1998-2003 (N= 321) 2004-2008 (N=360) p value* All cases (N=681)
Treatments 321 % 360 % 681 %
No treatment 0.65
Yes 10 3.1 9 2.5 19 2.8
No 306 95.3 340 94.4 646 94.9
Unknown 5 1.6 11 3.1 16 2.3
Surgery alone <0.001
Yes 36 11.2 16 4.4 52 7.6
No 254 79.1 328 91.1 582 85.5
Unknown 31 9.7 16 4.4 47 6.9
Hormone therapy 0.001
Yes 21 6.5 53 14.7 74 10.9
No 264 82.2 282 78.3 546 80.2
Unknown 36 11.2 25 6.9 61 9.0
Breast conserving surgery plus adjuvant therapy 0.63
Yes 113 35.2 125 34.7 238 34.9
No 193 60.1 231 64.2 424 62.3
Unknown 15 4.7 4 1.1 19 2.8
Mastectomy plus adjuvant therapy 0.52
Yes 95 29.6 116 32.2 211 31.0
No 210 65.4 230 63.9 440 64.6
Unknown 16 5.0 14 3.9 30 4.4
Others† 0.43
Yes 10 3.1 16 4.4 26 3.8
No 275 85.7 319 88.6 594 87.2
Unknown 36 11.2 25 6.9 61 9.0

Abbreviations: N = number of patients.

*Chi 2 test.

†Others: chemotherapy alone, radiotherapy alone, chemotherapy plus hormone therapy, chemotherapy plus radiotherapy, radiotherapy plus hormone therapy, chemotherapy plus radiotherapy plus hormone therapy, neoadjuvant chemotherapy plus surgery plus adjuvant therapy, neoadjuvant chemotherapy plus surgery.

Dialla et al.

Dialla et al. BMC Cancer 2012 12:472   doi:10.1186/1471-2407-12-472

Open Data